Q&A clinic on Substance, Organisation, Referentials Management Services - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 May 2026, 11:00 (CEST) to 12 May 2026, 12:00 (CEST)

SPOR and XEVMPD status update webinar - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2026, 10:00 (CEST) to 8 July 2026, 12:30 (CEST)

SPOR and XEVMPD status update webinar - Q4 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 7 October 2026, 10:00 (CEST) to 7 October 2026, 12:30 (CEST)

Agenda of the COMP meeting 2-3 December 2025

PSUSA/00010883/202504

PSUSA/00003097/202501

Human medicines European public assessment report (EPAR): Rasagiline Viatris (previously Rasagiline Mylan), rasagiline, Date of authorisation: 04/04/2016, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Benepali, etanercept, Date of authorisation: 13/01/2016, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Xelevia, sitagliptin, Date of authorisation: 21/03/2007, Revision: 42, Status: Authorised

Human medicines European public assessment report (EPAR): Cerezyme, imiglucerase, Date of authorisation: 17/11/1997, Revision: 34, Status: Authorised